Today's top medical abstracts
Oncology
Become a Member Today!
Email
Password
Remember me
Forgot your Password?

Invite Code?

Home
General Oncology
For Practicing
Oncologists
Conferences
Jobs
Newsletters
My Library
Topics in
Oncology
        Alternative Therapies
        Anemia/Polycythemia
        BMT/SCT
        Basic Science/Genetics
        Bone/Cartilage
        Breast
        Carcinogenesis
        Coagulation/Bleeding Dz
        Colorectal Cancer/Polyps
        Dermatologic Oncology
        Diagnostics/Radiology
        Economics of Medicine
        Endocrine Oncology
        GI Oncology
        Gynecologic Oncology
        Head and Neck
        Hepatobiliary/Pancreas
        Leukemia/Lymphoma
        Lung/Thoracic Oncology
        Myeloproliferative Dz
        Neurologic Oncology
        Pain/Palliative Care
        Pediatric Heme/Oncology
        Pharmacology/Therapy
        Popular Press
        Renal/Urologic
        Side Effects
        Soft Tissue/Sarcoma
        Transfusion Medicine
 
Help
Resource Center
RSS News Feeds
Send Newsletter
to a Friend
 
Sponsor
For Practicing Oncologists
Providers Satisfied with Carriers/MACs
Roberta Buell, MBA, Sausalito Healthcare Partners
Cancer Science: Mutations in the ALK Receptor Kinase cause Neuroblastoma
Sara Hartley, MDLinx Oncology
Technology Advances: Laser Microscopy Offers Vista of Real-Time Cell Movements
Dorothy J. Schirf, MD, MDLinx Oncology
  See all
Article Summary

Click the title below to leave the MDLinx Network and go to the Journal's Website
Breast cancer risk and hormone receptor status in older women by parity, age of first birth, and breastfeeding: A case-control study
Cancer Epidemiology, Biomarkers & Prevention, 07/21/08
Print     Email This Article     Save in My Library   Free Abstract
Lord SJ et al. - These findings suggest that the effect of parity on a woman's long-term risk of breast cancer is modified by age at first full-term pregnancy and possibly by breastfeeding.

Methods
  • Study to investigate whether age at first birth (<25 or ≥25 yrs) and breastfeeding (ever/never) modify the long-term effect on risk of ERPR(+) and (-) cancer
  • 1,457 incident BCa cases and 1,455 controls ages ≥55 yrs

Results
  • Women who gave birth before age 25 yrs had a 36% reduced risk of BCa vs nulligravida
  • This was not observed for women who started their families at an older age
  • This protective effect was restricted to ERPR(+) BCa
  • Late age at first birth increased the risk of ERPR(-) cancers
  • Additional births reduced the risk of ERPR(+) cancers among women with an early first birth
  • And also among women who breastfed but not among older mothers or those who never breastfed
  • In women with a late first birth who never breastfed, multiparity was associated with increased risk of BCa

 

--- BASIC SCIENCE/GENETICS TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



 

--- BREAST TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



 

Sponsor
--- ENDOCRINE ONCOLOGY TOP ARTICLES ---

Receive free subspecialty "5-minute updates" via email



Sponsor
Read a Different Specialty
Allergy/Immunology
Anesthesiology
Cardiology
Dermatology
Drugs
Emergency Medicine
Endocrinology
ENT
Family Medicine
Gastroenterology
Hematology-Oncology
Infectious Disease
Internal Medicine
Nephrology
Neurology
OB/Gyn
Ophthalmology
Orthopedics
Pediatrics
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology
Profession Index
Dentist
Hospital Administrator
Nurse
    Medical Students
Nurse Practitioner
Pharma/Drug Marketer
    Pharmacist
Physician
Physician Assistants
Article Search
Keyword:
Search:
Published within:
Sort By:
Date Relevance
    
Sponsor
Sponsor
About MDLinx  |  Contact  |  Advertise with MDLinx  |  Site Map  |  Privacy Policy  |  Terms of Use  |  Sign Up For Newsletters  |  Recommend this Site

English |  Español |  Français |  Deutsch |  中文 |  Руccкий |  Norsk |  Nederlands |  Português |  Italiano

©1999-2008 MDLinx, Inc.